<DOC>
	<DOC>NCT00833456</DOC>
	<brief_summary>The purpose of the study is to monitor the general functional changes among patients with schizophrenia, treated with atypical antipsychotics dosed once daily for a period of 6 months.The primary study objective is to compare general functioning of patients with schizophrenia treated with Seroquel SR between baseline and the last study visit. The secondary study objectives are to compare general functioning of patients with schizophrenia treated with other atypical antipsychotic medicinal products administered once daily between baseline and the last study visit, monitoring of other indicators of clinical improvement, evaluation of patient compliance and assessment of occurrence of adverse effects</brief_summary>
	<brief_title>NIS to Observe Improvement in Global Assessment of Functioning in Patients With Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>patients have a diagnosis of schizophrenia, as defined by DSMIVTR patients' symptoms are controlled with Seroquel SR started up to 1 month before the inclusion or patients' symptoms are controlled with other atypical antipsychotic in once daily formulation started up to 1 month before the inclusion patients who are treated with Seroquel SR or other antipsychotic more than 1 month patients with prescribed antipsychotic combinations pregnant women or women who are breastfeeding patients who have been treated with antipsychotics in depot formulations for the last two months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>schizophrenia</keyword>
	<keyword>Seroquel SR</keyword>
	<keyword>atypical antipsychotics</keyword>
	<keyword>assessment of functioning</keyword>
	<keyword>GAF scale</keyword>
</DOC>